LifeStance Health Net Income 2020-2023 | LFST
LifeStance Health net income from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| LifeStance Health Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-186 |
| 2022 | $-216 |
| 2021 | $-344 |
| 2020 | $-311 |
| 2019 | $-59 |
| LifeStance Health Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-45 |
| 2023-09-30 | $-62 |
| 2023-06-30 | $-45 |
| 2023-03-31 | $-34 |
| 2022-12-31 | $-47 |
| 2022-09-30 | $-38 |
| 2022-06-30 | $-69 |
| 2022-03-31 | $-62 |
| 2021-12-31 | $-108 |
| 2021-09-30 | $-120 |
| 2021-06-30 | $-70 |
| 2021-03-31 | $-45 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-32 |
| 2020-03-31 | $2 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.355B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.465B | 9.96 |
| Quest Diagnostics (DGX) | United States | $15.044B | 15.55 |
| DaVita (DVA) | United States | $11.644B | 15.84 |
| Chemed (CHE) | United States | $8.667B | 26.91 |
| Encompass Health (EHC) | United States | $8.285B | 21.32 |
| Elanco Animal Health (ELAN) | United States | $6.443B | 14.65 |
| Option Care Health (OPCH) | United States | $5.091B | 19.27 |
| RadNet (RDNT) | United States | $3.345B | 97.70 |
| Amedisys (AMED) | United States | $2.978B | 21.10 |
| Astrana Health (ASTH) | United States | $2.048B | 25.57 |
| U.S Physical Therapy (USPH) | United States | $1.513B | 39.21 |
| Addus HomeCare (ADUS) | United States | $1.501B | 22.81 |
| Pennant (PNTG) | United States | $0.610B | 35.63 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.308B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.009B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.006B | 0.00 |